NCT03275233 is a clinical trial in Painful Peripheral Neuropathy, sponsored by Assiut University.

Who is sponsoring NCT03275233?

NCT03275233 is sponsored by Assiut University.

What condition does NCT03275233 study?

NCT03275233 studies Painful Peripheral Neuropathy.

Is NCT03275233 still recruiting?

NCT03275233 is currently status unknown. Last updated 22 April 2019.

Last reviewed 2019-04-22 · How we verify

NCT03275233

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Psychiatric Comorbidities in Patients With Painful Peripheral Neuropathy

Status unknown Last updated 22 April 2019

What this trial tests

trial in Painful Peripheral Neuropathy in 40 participants. Status unknown.

Timeline

4 September 2019

Primary endpoint
4 January 2020

4 January 2021

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	40
Start date	4 September 2019
Primary completion	4 January 2020
Estimated completion	4 January 2021

Conditions studied

Painful Peripheral Neuropathy — all drugs for Painful Peripheral Neuropathy →

Sponsor

Assiut University

Who can join

Adults 18 to 66, any sex, with Painful Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Psychiatric comorbidities in patient with Painful Peripheral neuropathy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03275233 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 22 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03275233.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing